Your browser doesn't support javascript.
loading
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.
Laetsch, Theodore W; Maude, Shannon L; Rives, Susana; Hiramatsu, Hidefumi; Bittencourt, Henrique; Bader, Peter; Baruchel, André; Boyer, Michael; De Moerloose, Barbara; Qayed, Muna; Buechner, Jochen; Pulsipher, Michael A; Myers, Gary Douglas; Stefanski, Heather E; Martin, Paul L; Nemecek, Eneida; Peters, Christina; Yanik, Gregory; Khaw, Seong Lin; Davis, Kara L; Krueger, Joerg; Balduzzi, Adriana; Boissel, Nicolas; Tiwari, Ranjan; O'Donovan, Darragh; Grupp, Stephan A.
Afiliación
  • Laetsch TW; Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Maude SL; Department of Pediatrics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Rives S; Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Hiramatsu H; Department of Pediatric Hematology-Oncology and Institut de Recerca, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.
  • Bittencourt H; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Bader P; Department of Pediatrics, Faculty of Medicine, University of Montreal, Montreal, Canada.
  • Baruchel A; The Hematology Oncology Division and Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine, Montreal, Canada.
  • Boyer M; Division of Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, University Hospital Frankfurt, Frankfurt, Germany.
  • De Moerloose B; University Hospital Robert Debré (APHP) and Université de Paris, Paris, France.
  • Qayed M; Department of Pediatrics and Internal Medicine, University of Utah, Salt Lake City, UT.
  • Buechner J; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
  • Pulsipher MA; Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA.
  • Myers GD; Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.
  • Stefanski HE; Division of Hematology, Oncology, Blood and Marrow Transplant, Children's Hospital Los Angeles, USC Keck School of Medicine, Los Angeles, CA.
  • Martin PL; At the time of present work, now affiliated with Division of Pediatric Hematology and Oncology, Intermountain Primary Children's Hospital, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.
  • Nemecek E; Children's Mercy Hospital and Clinics, Kansas City, MO.
  • Peters C; National Bone Marrow Donor Program, Be the Match, Division of Pediatric Blood and Marrow Transplant, University of Minnesota, Minneapolis, MN.
  • Yanik G; Pediatric Transplant and Cellular Therapy, Duke University Medical Center, Durham, NC.
  • Khaw SL; Oregon Health and Science University, Portland, OR.
  • Davis KL; Stem Cell Transplantation Unit, St Anna Children's Hospital, Vienna, Austria.
  • Krueger J; Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, MI.
  • Balduzzi A; Children's Cancer Centre, Royal Children's Hospital and Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Boissel N; Division of Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA.
  • Tiwari R; Division of Haematology/Oncology/Bone Marrow Transplantation, Hospital for Sick Children, Toronto, Canada.
  • O'Donovan D; Clinica Pediatrica Università degli Studi di Milano Bicocca, Monza, Italy.
  • Grupp SA; Saint-Louis Hospital (APHP) and Université de Paris Diderot, Paris, France.
J Clin Oncol ; 41(9): 1664-1669, 2023 03 20.
Article en En | MEDLINE | ID: mdl-36399695

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Prognostic_studies Aspecto: Patient_preference Límite: Adult / Child / Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Panamá Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Prognostic_studies Aspecto: Patient_preference Límite: Adult / Child / Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Panamá Pais de publicación: Estados Unidos